Cytomegalovirus RetinitisCytomegalovirusRetinitisBlindnessFoscarnetCytomegalovirus InfectionsRetinitis PigmentosaGanciclovirAIDS-Related Opportunistic InfectionsEye Infections, ViralAntiviral AgentsMuromegalovirusNight BlindnessAcquired Immunodeficiency SyndromeHemorrhageCerebral HemorrhageInterleukin-10 Receptor alpha SubunitSubarachnoid HemorrhageOrganophosphorus CompoundsOrganophosphonatesCytosineDrug ImplantsVisual AcuityPhosphonoacetic AcidBlindness, CorticalCD4 Lymphocyte CountVitreous BodyAntiretroviral Therapy, Highly ActiveHerpesviridae InfectionsIntracranial HemorrhagesCytomegalovirus VaccinesElectroretinographyIntravitreal InjectionsRetinal HemorrhageInjectionsInjections, IntravenousProspective StudiesVision, LowEye ProteinsPostpartum HemorrhageViral LoadDrug Therapy, CombinationGastrointestinal HemorrhageRhodopsinImmediate-Early ProteinsTreatment OutcomeRetrospective StudiesRetinaOnchocerciasis, OcularDNA, ViralRetinal DegenerationCataractCD4-Positive T-LymphocytesAnti-HIV AgentsViral ProteinsVitreous Hemorrhage